Enhancement of DNA vaccine potency using conventional aluminum adjuvants (Q46963372)

26 December 2017

title

Enhancement of DNA vaccine potency using conventional aluminum adjuvants (English)

1 reference

26 December 2017

0 references

Ulmer JB

1

1 reference

26 December 2017

DeWitt CM

2

1 reference

26 December 2017

Chastain M

3

1 reference

26 December 2017

Friedman A

4

1 reference

26 December 2017

Donnelly JJ

5

1 reference

26 December 2017

McClements WL

6

1 reference

26 December 2017

Caulfield MJ

7

1 reference

26 December 2017

Bohannon KE

8

1 reference

26 December 2017

Volkin DB

9

1 reference

26 December 2017

Evans RK

10

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

26 December 2017

published in

Vaccine

1 reference

26 December 2017

volume

18

1 reference

26 December 2017

page(s)

18-28

1 reference

26 December 2017

issue

1-2

1 reference

26 December 2017

Direct introduction of genes into rats and expression of the genes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

1 reference

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Liposome-mediated DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Current status of immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

DNA immunization against experimental genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

Adjuvant Effects of Amorphous Silica and of Aluminium Hydroxide on IgE and IgG<sub>1</sub> Antibody Production in Different Inbred Mouse Strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900151-6

7 January 2021

10.1016/S0264-410X(99)00151-6

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

10501231

1 reference

26 December 2017